Sanofi Lands ADEL’s Tau-Targeting Alzheimer’s Contender In $1Bn Deal

Promising Differentiated Mechanism Highlighted

 
• By Jung Won Shin
  
Alzheimer's disease
ADEL/Sanofi Alzheimer's Another Block In Busy 2025 Korean Deal Space (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business